MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

What Were the Key Insights from Elanco's William Blair Presentation

7 hours ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Were the Key Takeaways from Resideo's J.P. Morgan Conference Presentation

2 weeks ago

What Were the Key Highlights from Beam's RBC Conference Presentation

1 week ago

What Were HCW Biologics' Key Developments in Q1 2026

2 weeks ago

What Should Investors Expect from Parker Hannifin's Presentation

2 months ago

Elanco Animal Health Incorporated (ELAN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

Elanco Animal Health (ELAN) provided a business update at the 46th Annual William Blair Growth Stock Conference. The presentation focused on strategic growth initiatives and operational performance, o...

ELAN

Stock News•2 weeks ago

Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market

Elanco Animal Health launched Befrena (tirnovetmab), an anti-IL-31 monoclonal antibody for canine dermatitis, into the $1.3B U.S. market. The injection provides 6 to 8 weeks of itch relief, aiming to ...

ELAN

Stock News•3 weeks ago

Zoetis Q1 Review: Is A Darkened Outlook Cyclical Or Structural? (Rating Downgrade)

Zoetis US companion animal sales fell 11% YoY in Q1, driven by generic competition for legacy drugs Convenia and Cerenia. While international and livestock segments provided partial offsets, structura...

ZTS

Stock News•3 weeks ago

'WE WILL BE PREPARED': Inside efforts to stop screwworm outbreak

Elanco Animal Health CEO Jeff Simmons confirmed the company is preparing for a potential screwworm outbreak. The firm is coordinating biosecurity and veterinary response efforts to mitigate risks to l...

ELAN